Pieper Steven sold XERS
August 12, 2026 · Form 4 insider transaction
Pieper Steven sold 5,000 shares of Xeris Biopharma Holdings, Inc. at $8.50 per share, a transaction worth $42.5K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 0 days after the transaction.
Direction
Disposed (sell-side)
Shares
5,000
Price
$8.50
Total value
$42.5K
InsiderPieper Steven
Role—
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateAugust 12, 2026
Filing dateAugust 12, 2026
Shares owned after1,361,053
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 18, 2025.